NCT04955808 2026-04-13
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
Suspended
Clinical Trials
27 trialsNCT05597878 2026-03-06
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2/3 Suspended
NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT06144619 2026-02-09
Non-Invasive Biomarkers in Prostate Cancer Disease Management
H. Lee Moffitt Cancer Center and Research Institute
Suspended
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT04981834 2026-01-16
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
University of Southern California
Phase NA Suspended
NCT05064111 2025-12-03
Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy
University of Arizona
Suspended
NCT05362032 2025-10-24
Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate
OHSU Knight Cancer Institute
Phase NA Suspended
NCT05445609 2025-09-19
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Emory University
Phase 2 Suspended
NCT05820633 2025-09-12
PCS-XI
CHU de Quebec-Universite Laval
Phase NA Suspended
NCT03694483 2025-08-22
Prostasomes as Diagnostic Tool for Prostate Cancer Detection
Hackensack Meridian Health
Suspended
NCT05958199 2025-06-27
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Phase 1 Suspended
NCT06643494 2025-03-11
Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
Optimal Health Research
Phase 1/2 Suspended
NCT04684628 2024-05-02
68Ga-PSMA PET/CT in Prostate Cancer
University of Saskatchewan
Phase 3 Suspended
NCT06355843 2024-04-09
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
The First Affiliated Hospital of Anhui Medical University
Phase NA Suspended
NCT05361915 2024-03-18
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
NCT06185478 2023-12-29
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase NA Suspended
NCT03970382 2022-08-18
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
PACT Pharma, Inc.
Phase 1 Suspended
NCT03321864 2020-07-10
CAPTURE
Cambridge University Hospitals NHS Foundation Trust
Phase NA Suspended
NCT02091661 2020-03-25
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer
University of Rome Tor Vergata
Phase 3 Suspended
NCT03734575 2019-07-11
ClariCore System Used in Transperineal Prostate Biopsy
Precision Biopsy, Inc.
Phase NA Suspended
NCT00664196 2016-06-17
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Roger Williams Medical Center
Phase 1 Suspended
NCT01337518 2012-12-18
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Enzon Pharmaceuticals, Inc.
Phase 1 Suspended
NCT01604863 2012-11-01
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Phase 1 Suspended
NCT00909558 2010-02-24
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Phase 1 Suspended
NCT00103623 2006-09-19
The Plenaxis® Experience Study
PRAECIS Pharmaceuticals Inc.
Phase 4 Suspended
NCT00127088 2006-09-11
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Suspended